Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Voya

Voya Small Cap Growth Fund Class I (TCMSX)

Ticker TCMSX · Since 2004-10-01 · · Holdings as of May 31, 2026

Expense ratio
0.95%$95/yr per $10k
5-yr return
+8.1%annualized
1-yr return
+14.5%as of Dec 2025
Net assets
$2.1Ball share classes
Holdings
100

Bottom line

Is TCMSX a good fund? The bottom line

TCMSX is the Class I share class of Voya Small Cap Growth Fund, an actively managed small-cap mutual fund from Voya.

Its expense ratio is 0.95% — about $95 a year on every $10,000 invested, cheaper than 53% of small-cap funds we track.

It returned +14.5% over one year, +8.1% a year over five years, +13.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $2.1 billion in net assets and 100 holdings, its largest position is Morgan Stanley Institutional Liquidity Funds (3.7%) and the top 10 make up 21.5% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • High turnover (132% a year) can mean more taxable distributions

Updated Nov 19, 2026

What TCMSX invests in

The Fund seeks long-term capital appreciation.

Under normal circumstances, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in investments tied to small-capitalization growth companies. For purposes of this 80% policy, small-capitalization growth companies means companies with market capitalizations that fall within the capitalization range of companies within the Russell 2000 Index (the Index) and that the Fund expects to generate capital appreciation. The market capitalization of companies within the Index will change with market conditions. As of June 30, 2026, the market capitalization of companies within the Index ranged from $ 8.5 million to $14.2 billion. As of June 30, 2026, the average weighted market capitalization of the Fund was $ 21.4 billion, while the average weighted market capitalization of the Index was $4.1 billion. The sub-adviser (the Sub-Adviser) uses…

From the fund's prospectus (filed Sep 25, 2026).

TCMSX performance

Fund calendar-year total returns, 2015–2024 2015: −1.0%; 2016: +16.0%; 2017: +24.7%; 2018: −5.7%; 2019: +33.3%; 2020: +27.9%; 2021: +18.2%; 2022: −23.6%; 2023: +20.3%; 2024: +18.6% −1% 2015 +16% 2016 +25% 2017 −6% 2018 +33% 2019 +28% 2020 +18% 2021 −24% 2022 +20% 2023 +19% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
TCMSX+14.5%+8.1%+13.1%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full TCMSX performance history →

What TCMSX costs

On a $10,000 investment, TCMSX's 0.95% expense ratio costs about $95 a year. The prospectus estimates $1,199 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full TCMSX fee table →

TCMSX top 10 holdings

#Holding% of fund
1Morgan Stanley Institutional Liquidity Funds3.69%
2Silicon Motion Technology Corp SIMO2.69%
3Bloom Energy Corp BE2.47%
4Standex International Corp SXI2.17%
5Brightspring Health Services Inc BTSG2.06%
6Allegro Microsystems Inc ALGM1.83%
7Casella Waste Systems Inc CWST1.75%
8Five Below Inc FIVE1.68%
9Mercury Systems Inc MRCY1.56%
10Onto Innovation Inc ONTO1.56%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 21.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to TCMSX

More funds like TCMSX →

TCMSX FAQ

What is the expense ratio of TCMSX?
TCMSX's expense ratio is 0.95%, which works out to about $95 a year for every $10,000 invested. The prospectus estimates total costs of $1,199 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is TCMSX a good investment?
It depends on your goals, but the data points to: no front-end sales load; high turnover (132% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does TCMSX hold?
TCMSX's largest holdings are Morgan Stanley Institutional Liquidity Funds (3.7%), Silicon Motion Technology Corp (2.7%), Bloom Energy Corp (2.5%), Standex International Corp (2.2%), Brightspring Health Services Inc (2.1%). It holds 100 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is TCMSX's 5-year return?
TCMSX returned +8.1% a year over the five years ending Dec 31, 2025, and +13.1% a year over ten years. Past performance does not guarantee future results.
Does TCMSX have a sales load?
No. TCMSX has no front-end sales charge.
Who manages TCMSX?
TCMSX is offered by Voya through Voya EQUITY TRUST.